跳至主要内容
临床试验/CTRI/2020/01/022966
CTRI/2020/01/022966尚未招募不适用

Comparative Clinical Evaluation of Samasharkara Churna with Kankayan Vati in the management of Arsha with special reference to Haemorrhoids

Dr Shruti shukla1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年1月31日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Reduction in Sign n Symptoms of the condition like Agnimandya,Gud kandu,Malavshtambh,Gudshoola,Gudgat Raktastrava

研究概览

简要总结

This study is a comparative Clinical Evaluation of Samasharkara Churna with Kankayan Vati in the management of Arsha with special reference to Haemorrhoids in 100 patients with internal hemorrhoidsof 1 & 2nd degree, in aarogyshala rugnalaya ,ganeshwadi, panchvati,nashik. The objective of this study is to observe reduction in symtoms and demolition of pathophysiology of hemorrhoids for a month.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with Internal Haemorrhoids of I & II degree 2) Patients having following clinical features of Arsha : a) Agnimandya b) Malavshtambha c) Gudashula d) SaraktaMalapravrutti e) Gudakandu 3) Patients willing to participate with informed written consent.

排除标准

  • Patients below age 20 years & above the age of 70 years 2) Patients with any major illness such as CA Large intestine, anal canal and rectum, Rectal Polyps, Fistula in ano, Ulcerative colitis.
  • Pregnant women and lactating mothers.
  • 9 4) Known cases of Diabetes mellitus as the trial drug is sugar based.
  • Severe anaemic patient 6) Patients with Bleeding Disorders, Crohn’s Disease, Liver cirrhosis, portal hypertension.

结局指标

主要结局

Reduction in Sign n Symptoms of the condition like Agnimandya,Gud kandu,Malavshtambh,Gudshoola,Gudgat Raktastrava

时间窗: 1 Month

次要结局

  • Prevention of Occurrence of thrombosed piles,anorexia and Anaemia(1 month)

研究者

发起方
Dr Shruti shukla
申办方类型
Other [individual]

研究点 (1)

Loading locations...

相似试验